http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2415862-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7561596eb333b37530ed35c7efc9bb19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f518c5177fd1bf3b8e6541a170383e83
publicationDate 2002-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2415862-A1
titleOfInvention Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
abstract Pharmaceutical preparation for the treatment and follow-up care of tumors that comprises the blood plasma or predetermined blood plasma components of equidae animals with pair number of fingers, preferably cattle being not endangered lethally by leucosis . The predetermined fraction is the material "bovin 40" and/or "bovin 300" constituting the difference detectable by electrophoresis between the lipid-free fraction taken from a healthy cattle. In the separation method of the required fraction the initial blood is optionally treated by an anti-coagulant and the corpuscles are separated therefrom, the plasma fraction is treated by a first organic solvent, then a surfactant material composed of fine grains is added thereto, the liquid is mixed and the lipid-free fraction bound to the grains is separated from the liquid components by centrifugation, and the separated fraction is brought again into a solution.
priorityDate 2000-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2083
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9KQ30
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506910
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ61503
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1YDF6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8A507
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05927
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4907
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID916883
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20646
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23959
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7CT96
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527523
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9I767
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407563347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841936
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID878495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID986721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID178457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8CE08
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID754
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22848
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56318
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8DFG4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693

Total number of triples: 51.